Intellia Therapeutics, Inc. (NTLA)

11.75 -0.41 (-3.37%) USD  |  NASDAQ  |  Sep 25, 16:00
11.77 +0.02 (+0.17%) After-Hours: 19:59
More

Intellia Therapeutics Cash and Short Term Investments (Annual) : 449.88M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for NTLA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2014. Start Trial.
Date Value
December 31, 2025 449.88M
December 31, 2024 601.52M
December 31, 2023 912.22M
December 31, 2022 1.193B
December 31, 2021 748.69M
December 31, 2020 600.07M
Date Value
December 31, 2019 279.73M
December 31, 2018 314.06M
December 31, 2017 340.68M
December 31, 2016 273.06M
December 31, 2015 75.82M
December 31, 2014 9.845M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Twist Bioscience Corp. 232.43M
Beam Therapeutics, Inc. 1.245B
Prime Medicine, Inc. 177.68M
Moderna, Inc. 5.80B
Q32 Bio, Inc. 48.30M